Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Pihlstrøm L[au]:

Search results

Items: 46

1.

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts.

Iwaki H, Blauwendraat C, Leonard HL, Liu G, Maple-Grødem J, Corvol JC, Pihlstrøm L, van Nimwegen M, Hutten SJ, Nguyen KH, Rick J, Eberly S, Faghri F, Auinger P, Scott KM, Wijeyekoon R, Van Deerlin VM, Hernandez DG, Day-Williams AG, Brice A, Alves G, Noyce AJ, Tysnes OB, Evans JR, Breen DP, Estrada K, Wegel CE, Danjou F, Simon DK, Ravina B, Toft M, Heutink P, Bloem BR, Weintraub D, Barker RA, Williams-Gray CH, van de Warrenburg BP, Van Hilten JJ, Scherzer CR, Singleton AB, Nalls MA.

Neurol Genet. 2019 Jul 9;5(4):e348. doi: 10.1212/NXG.0000000000000348. eCollection 2019 Aug.

2.

Missense mutations in DYT-TOR1A dystonia.

Iqbal Z, Koht J, Pihlstrøm L, Henriksen SP, Cappelletti C, Russel MB, Norberto de Souza O, Skogseid IM, Toft M.

Neurol Genet. 2019 Jun 6;5(4):e343. doi: 10.1212/NXG.0000000000000343. eCollection 2019 Aug. No abstract available.

3.

GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study.

Rongve A, Witoelar A, Ruiz A, Athanasiu L, Abdelnour C, Clarimon J, Heilmann-Heimbach S, Hernández I, Moreno-Grau S, de Rojas I, Morenas-Rodríguez E, Fladby T, Sando SB, Bråthen G, Blanc F, Bousiges O, Lemstra AW, van Steenoven I, Londos E, Almdahl IS, Pålhaugen L, Eriksen JA, Djurovic S, Stordal E, Saltvedt I, Ulstein ID, Bettella F, Desikan RS, Idland AV, Toft M, Pihlstrøm L, Snaedal J, Tárraga L, Boada M, Lleó A, Stefánsson H, Stefánsson K, Ramírez A, Aarsland D, Andreassen OA.

Sci Rep. 2019 May 7;9(1):7013. doi: 10.1038/s41598-019-43458-2.

4.

Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms.

Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstrøm L, Simón-Sánchez J, Schulte C, Sharma M, Krohn L, Siitonen A, Iwaki H, Leonard H, Noyce AJ, Tan M, Gibbs JR, Hernandez DG, Scholz SW, Jankovic J, Shulman LM, Lesage S, Corvol JC, Brice A, van Hilten JJ, Marinus J; 23andMe Research Team, Eerola-Rautio J, Tienari P, Majamaa K, Toft M, Grosset DG, Gasser T, Heutink P, Shulman JM, Wood N, Hardy J, Morris HR, Hinds DA, Gratten J, Visscher PM, Gan-Or Z, Nalls MA, Singleton AB; International Parkinson's Disease Genomics Consortium (IPDGC).

Mov Disord. 2019 Jun;34(6):866-875. doi: 10.1002/mds.27659. Epub 2019 Apr 7.

PMID:
30957308
5.

Assessment of APOE in atypical parkinsonism syndromes.

Sabir MS, Blauwendraat C, Ahmed S, Serrano GE, Beach TG, Perkins M, Rice AC, Masliah E, Morris CM, Pihlstrom L, Pantelyat A, Resnick SM, Cookson MR, Hernandez DG, Albert M, Dawson TM, Rosenthal LS, Houlden H, Pletnikova O, Troncoso J, Scholz SW.

Neurobiol Dis. 2019 Jul;127:142-146. doi: 10.1016/j.nbd.2019.02.016. Epub 2019 Feb 21.

PMID:
30798004
6.

The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease.

Bandres-Ciga S, Saez-Atienzar S, Bonet-Ponce L, Billingsley K, Vitale D, Blauwendraat C, Gibbs JR, Pihlstrøm L, Gan-Or Z; International Parkinson's Disease Genomics Consortium (IPDGC), Cookson MR, Nalls MA, Singleton AB.

Mov Disord. 2019 Apr;34(4):460-468. doi: 10.1002/mds.27614. Epub 2019 Jan 24.

PMID:
30675927
7.

LRP10 in α-synucleinopathies.

Pihlstrøm L, Schottlaender L, Chelban V, Houlden H; MSA Exome Consortium.

Lancet Neurol. 2018 Dec;17(12):1033-1034. doi: 10.1016/S1474-4422(18)30407-1. Epub 2018 Nov 13. No abstract available.

PMID:
30507385
8.

Understanding the role of genetic variability in LRRK2 in Indian population.

Kishore A, Ashok Kumar Sreelatha A, Sturm M, von-Zweydorf F, Pihlstrøm L, Raimondi F, Russell R, Lichtner P, Banerjee M, Krishnan S, Rajan R, Puthenveedu DK, Chung SJ; International Parkinson's Disease Genomics Consortium (IPDGC); Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (COURAGE-PD), Bauer P, Riess O, Gloeckner CJ, Kruger R, Gasser T, Sharma M.

Mov Disord. 2019 Apr;34(4):496-505. doi: 10.1002/mds.27558. Epub 2018 Nov 28.

PMID:
30485545
9.

A paradoxical relationship between family history, onset age, and genetic risk in Parkinson's disease.

Kristiansen M, Maple-Grødem J, Alves G, Arepalli S, Hernandez DG, Iwaki H, Nalls MA, Singleton A, Tysnes OB, Toft M, Pihlstrøm L.

Mov Disord. 2019 Feb;34(2):298-299. doi: 10.1002/mds.27555. Epub 2018 Nov 28. No abstract available.

PMID:
30484896
10.

No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's disease.

Berge-Seidl V, Pihlstrøm L, Wszolek ZK, Ross OA, Toft M.

Neurobiol Aging. 2019 Feb;74:236.e1-236.e5. doi: 10.1016/j.neurobiolaging.2018.09.022. Epub 2018 Sep 22.

PMID:
30340792
11.

A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease.

Pihlstrøm L, Blauwendraat C, Cappelletti C, Berge-Seidl V, Langmyhr M, Henriksen SP, van de Berg WDJ, Gibbs JR, Cookson MR; International Parkinson Disease Genomics Consortium; North American Brain Expression Consortium, Singleton AB, Nalls MA, Toft M.

Ann Neurol. 2018 Jul;84(1):117-129. doi: 10.1002/ana.25274. Epub 2018 Aug 26.

PMID:
30146727
12.

Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease.

Blauwendraat C, Reed X, Kia DA, Gan-Or Z, Lesage S, Pihlstrøm L, Guerreiro R, Gibbs JR, Sabir M, Ahmed S, Ding J, Alcalay RN, Hassin-Baer S, Pittman AM, Brooks J, Edsall C, Hernandez DG, Chung SJ, Goldwurm S, Toft M, Schulte C, Bras J, Wood NW, Brice A, Morris HR, Scholz SW, Nalls MA, Singleton AB, Cookson MR; COURAGE-PD (Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson’s Disease) Consortium, the French Parkinson’s Disease Consortium, and the International Parkinson’s Disease Genomics Consortium (IPDGC).

JAMA Neurol. 2018 Nov 1;75(11):1416-1422. doi: 10.1001/jamaneurol.2018.1885.

13.

Lysosomal storage disorder gene variants in multiple system atrophy.

Pihlstrøm L, Schottlaender L, Chelban V; MSA Exome Consortium, Meissner WG, Federoff M, Singleton A, Houlden H.

Brain. 2018 Jul 1;141(7):e53. doi: 10.1093/brain/awy124. No abstract available.

14.

Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study.

Bjørnarå KA, Pihlstrøm L, Dietrichs E, Toft M.

BMC Neurol. 2018 Feb 21;18(1):20. doi: 10.1186/s12883-018-1023-6.

15.

Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease.

Blauwendraat C, Kia DA, Pihlstrøm L, Gan-Or Z, Lesage S, Gibbs JR, Ding J, Alcalay RN, Hassin-Baer S, Pittman AM, Brooks J, Edsall C, Chung SJ, Goldwurm S, Toft M, Schulte C; International Parkinson's Disease Genomics Consortium (IPDGC), COURAGE-PD Consortium, Hernandez D, Singleton AB, Nalls MA, Brice A, Scholz SW, Wood NW.

Neurobiol Aging. 2018 Apr;64:159.e5-159.e8. doi: 10.1016/j.neurobiolaging.2017.12.012. Epub 2017 Dec 20.

16.

Correction: Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia.

Iqbal Z, Rydning SL, Wedding IM, Koht J, Pihlstrøm L, Rengmark AH, Henriksen SP, Tallaksen CME, Toft M.

PLoS One. 2017 Oct 12;12(10):e0186571. doi: 10.1371/journal.pone.0186571. eCollection 2017.

17.

Genetics of neurodegenerative diseases: an overview.

Pihlstrøm L, Wiethoff S, Houlden H.

Handb Clin Neurol. 2017;145:309-323. doi: 10.1016/B978-0-12-802395-2.00022-5. Review.

PMID:
28987179
18.

The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.

Berge-Seidl V, Pihlstrøm L, Maple-Grødem J, Forsgren L, Linder J, Larsen JP, Tysnes OB, Toft M.

Neurosci Lett. 2017 Sep 29;658:48-52. doi: 10.1016/j.neulet.2017.08.040. Epub 2017 Aug 19.

PMID:
28830825
19.

NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases.

Blauwendraat C, Faghri F, Pihlstrom L, Geiger JT, Elbaz A, Lesage S, Corvol JC, May P, Nicolas A, Abramzon Y, Murphy NA, Gibbs JR, Ryten M, Ferrari R, Bras J, Guerreiro R, Williams J, Sims R, Lubbe S, Hernandez DG, Mok KY, Robak L, Campbell RH, Rogaeva E, Traynor BJ, Chia R, Chung SJ; International Parkinson's Disease Genomics Consortium (IPDGC), COURAGE-PD Consortium, Hardy JA, Brice A, Wood NW, Houlden H, Shulman JM, Morris HR, Gasser T, Krüger R, Heutink P, Sharma M, Simón-Sánchez J, Nalls MA, Singleton AB, Scholz SW.

Neurobiol Aging. 2017 Sep;57:247.e9-247.e13. doi: 10.1016/j.neurobiolaging.2017.05.009. Epub 2017 May 17.

20.

Use of advanced therapies for Parkinson's disease in Norway.

Ezat B, Pihlstrøm L, Aasly J, Tysnes OB, Egge A, Dietrichs E.

Tidsskr Nor Laegeforen. 2017 May 2;137(9):619-623. doi: 10.4045/tidsskr.16.0711. eCollection 2017 May. English, Norwegian.

21.

Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia.

Iqbal Z, Rydning SL, Wedding IM, Koht J, Pihlstrøm L, Rengmark AH, Henriksen SP, Tallaksen CM, Toft M.

PLoS One. 2017 Mar 31;12(3):e0174667. doi: 10.1371/journal.pone.0174667. eCollection 2017. Erratum in: PLoS One. 2017 Oct 12;12 (10 ):e0186571.

22.

Dr. Watson og vi.

Pihlstrøm L.

Tidsskr Nor Laegeforen. 2017 Mar 7;137(5):388. doi: 10.4045/tidsskr.17.0070. eCollection 2017 Mar. Norwegian. No abstract available.

PMID:
28272576
Free Article
23.

[Parkinson's disease and parkinsonism].

Faiz KW, Pihlstrøm L.

Tidsskr Nor Laegeforen. 2017 Feb 21;137(4):298. doi: 10.4045/tidsskr.16.0915. eCollection 2017 Feb. Norwegian. No abstract available.

24.

Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature.

Fagan ES, Pihlstrøm L.

Eur J Neurol. 2017 Apr;24(4):561-e20. doi: 10.1111/ene.13258. Epub 2017 Feb 21. Review.

PMID:
28220571
25.

Analysis of the prion protein gene in multiple system atrophy.

Chelban V, Manole A, Pihlstrøm L, Schottlaender L, Efthymiou S, OConnor E, Meissner WG, Holton JL, Houlden H.

Neurobiol Aging. 2017 Jan;49:216.e15-216.e18. doi: 10.1016/j.neurobiolaging.2016.09.021. Epub 2016 Oct 3.

26.

Når leger vet for mye.

Pihlstrøm L.

Tidsskr Nor Laegeforen. 2016 Oct 11;136(18):1570. eCollection 2016 Oct. Norwegian. No abstract available.

PMID:
27731607
Free Article
27.

Rare variants in dementia genes and Parkinson's disease.

Iqbal Z, Pihlstrøm L, Rengmark A, Henriksen SP, Linder J, Forsgren L, Toft M.

Eur J Hum Genet. 2016 Dec;24(12):1661-1662. doi: 10.1038/ejhg.2016.79. Epub 2016 Jun 22. No abstract available.

28.

Den kulturelle legekofferten.

Pihlstrøm L.

Tidsskr Nor Laegeforen. 2016 Jun 7;136(10):944. doi: 10.4045/tidsskr.16.0422. eCollection 2016 Jun. Norwegian. No abstract available.

29.

Low frequency of GCH1 and TH mutations in Parkinson's disease.

Rengmark A, Pihlstrøm L, Linder J, Forsgren L, Toft M.

Parkinsonism Relat Disord. 2016 Aug;29:109-11. doi: 10.1016/j.parkreldis.2016.05.010. Epub 2016 May 7.

PMID:
27185167
30.

A cumulative genetic risk score predicts progression in Parkinson's disease.

Pihlstrøm L, Morset KR, Grimstad E, Vitelli V, Toft M.

Mov Disord. 2016 Apr;31(4):487-90. doi: 10.1002/mds.26505. Epub 2016 Feb 8. Review.

PMID:
26853697
31.

[The wonders of practical teaching].

Pihlstrøm L.

Tidsskr Nor Laegeforen. 2015 Nov 3;135(20):1878. doi: 10.4045/tidsskr.15.1014. eCollection 2015 Nov 3. Norwegian. No abstract available.

32.

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.

Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschländer A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjigeorgiou GM, Hicks AA, Hattori N, Klein C, Jeon B, Kim YJ, Lesage S, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pihlstrøm L, Pramstaller PP, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Silburn PA, Theuns J, Tan EK, Tomiyama H, Toft M, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore DM, Krüger R, Sharma M; GEO-PD Consortium.

Neurology. 2015 Oct 13;85(15):1283-92. doi: 10.1212/WNL.0000000000002016. Epub 2015 Sep 9.

33.

Cumulative genetic risk and age at onset in Parkinson's disease.

Pihlstrøm L, Toft M.

Mov Disord. 2015 Oct;30(12):1712-3. doi: 10.1002/mds.26366. Epub 2015 Aug 3. No abstract available.

PMID:
26234887
34.

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.

Lill CM, Rengmark A, Pihlstrøm L, Fogh I, Shatunov A, Sleiman PM, Wang LS, Liu T, Lassen CF, Meissner E, Alexopoulos P, Calvo A, Chio A, Dizdar N, Faltraco F, Forsgren L, Kirchheiner J, Kurz A, Larsen JP, Liebsch M, Linder J, Morrison KE, Nissbrandt H, Otto M, Pahnke J, Partch A, Restagno G, Rujescu D, Schnack C, Shaw CE, Shaw PJ, Tumani H, Tysnes OB, Valladares O, Silani V, van den Berg LH, van Rheenen W, Veldink JH, Lindenberger U, Steinhagen-Thiessen E; SLAGEN Consortium, Teipel S, Perneczky R, Hakonarson H, Hampel H, von Arnim CAF, Olsen JH, Van Deerlin VM, Al-Chalabi A, Toft M, Ritz B, Bertram L.

Alzheimers Dement. 2015 Dec;11(12):1407-1416. doi: 10.1016/j.jalz.2014.12.009. Epub 2015 Apr 30.

35.

Fine mapping and resequencing of the PARK16 locus in Parkinson's disease.

Pihlstrøm L, Rengmark A, Bjørnarå KA, Dizdar N, Fardell C, Forsgren L, Holmberg B, Larsen JP, Linder J, Nissbrandt H, Tysnes OB, Dietrichs E, Toft M.

J Hum Genet. 2015 Jul;60(7):357-62. doi: 10.1038/jhg.2015.34. Epub 2015 Apr 9.

PMID:
25855069
36.

Parkinson's disease correlates with promoter methylation in the α-synuclein gene.

Pihlstrøm L, Berge V, Rengmark A, Toft M.

Mov Disord. 2015 Apr;30(4):577-80. doi: 10.1002/mds.26073. Epub 2014 Dec 27.

PMID:
25545759
37.

[Re: Affection for affection].

Pihlstrøm L.

Tidsskr Nor Laegeforen. 2014 Oct 28;134(20):1920. doi: 10.4045/tidsskr.14.1211. eCollection 2014 Oct 28. Norwegian. No abstract available.

38.

[Septic embolus].

Pihlstrøm L, Nedregaard B, Krossnes B, Aamodt AH.

Tidsskr Nor Laegeforen. 2014 May 13;134(9):945. doi: 10.4045/tidsskr.13.1656. eCollection 2014 May 13. Norwegian. No abstract available.

39.

Effective variant detection by targeted deep sequencing of DNA pools: an example from Parkinson's disease.

Pihlstrøm L, Rengmark A, Bjørnarå KA, Toft M.

Ann Hum Genet. 2014 May;78(3):243-52. doi: 10.1111/ahg.12060. Epub 2014 Mar 24.

40.

Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease.

Pihlstrøm L, Axelsson G, Bjørnarå KA, Dizdar N, Fardell C, Forsgren L, Holmberg B, Larsen JP, Linder J, Nissbrandt H, Tysnes OB, Ohman E, Dietrichs E, Toft M.

Neurobiol Aging. 2013 Jun;34(6):1708.e7-13. doi: 10.1016/j.neurobiolaging.2012.10.019. Epub 2012 Nov 13.

PMID:
23153929
41.

[The sardonic smile].

Pihlstrøm L.

Tidsskr Nor Laegeforen. 2011 Dec 13;131(24):2500-3. doi: 10.4045/tidsskr.11.0256. Norwegian. No abstract available.

42.

Climate change--the biggest health threat of our time.

Kvåle G, Fadnes LT, Tryland M, Pihlstrøm L.

Tidsskr Nor Laegeforen. 2011 Sep 6;131(17):1670-2. doi: 10.4045/tidsskr.11.0607. English, Norwegian. No abstract available.

43.

Parkinson's disease: What remains of the "missing heritability"?

Pihlstrøm L, Toft M.

Mov Disord. 2011 Sep;26(11):1971-3. doi: 10.1002/mds.23898. Epub 2011 Aug 2. No abstract available.

PMID:
21812035
44.

Genetic variability in SNCA and Parkinson's disease.

Pihlstrøm L, Toft M.

Neurogenetics. 2011 Nov;12(4):283-93. doi: 10.1007/s10048-011-0292-7. Epub 2011 Jul 29. Review.

PMID:
21800132
45.

[A 55-year old man with recurrent brain infarction].

Pihlstrøm L, Alfstad KÅ, Solyga V, Ringstad GA, Kerty E.

Tidsskr Nor Laegeforen. 2011 Jun 3;131(11):1089-91. doi: 10.4045/tidsskr.10.0162. Norwegian. No abstract available.

46.

[Effect of endurance exercises on cross-striated muscle cells].

Vihko V, Pihlström L.

Duodecim. 1977;93(18):1153-63. Finnish. No abstract available.

PMID:
590150

Supplemental Content

Loading ...
Support Center